| 18005909
|
Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. |
Explore (NY) |
2007 |
Lizogub VG;Riley DS;Heger M |
View
More |
| 21036571
|
Investigation of the influence of EPs(R) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. |
Phytomedicine |
2011 |
Michaelis M;Doerr HW;Cinatl J Jr |
View
More |
| 22381150
|
Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? |
Regul Toxicol Pharmacol |
2012 |
Teschke R;Frenzel C;Schulze J;Eickhoff A |
View
More |
| 27717933
|
Antiviral activity of the "Virus Blocking Factor" (VBF) derived i.a. from Pelargonium extract and Sambucus juice against different human-pathogenic cold viruses in vitro. |
Wiad Lek |
2016 |
Fal AM;Conrad F;Schonknecht K;Sievers H;Pawinska A |
View
More |
| 28478414
|
Antiviral activity of the "Virus Blocking Factor" (VBF) derived i.a. from Pelargonium extract and Sambucus juice against different human-pathogenic cold viruses in vitro. |
Wiad Lek |
2016 |
Fal AM;Conrad F;Schonknecht K;Sievers H;Pawinska A |
View
More |
| 30707726
|
Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells. |
PLoS One |
2019 |
Roth M;Fang L;Stolz D;Tamm M |
View
More |
| 33357221
|
Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts. |
BMC Complement Med Ther |
2020 |
Walther C;Doring K;Schmidtke M |
View
More |
